Replidyne
Latest round
- Series D
Last raised
- Sep 2005
Total raised
- $103M
Investors
- 8
About Replidyne
Replidyne is a privately held biopharmaceutical company focused on the discovery and development of new anti-infective drugs.
Who invested in Replidyne
8 investors across 2 rounds
See all investors in Replidyne
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Replidyne
Who invested in Replidyne?
Replidyne has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Replidyne raised?
Replidyne has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Replidyne last raise money?
Replidyne's most recent round on record is a Series D, in Sep 2005.
What does Replidyne do?
Replidyne is a privately held biopharmaceutical company focused on the discovery and development of new anti-infective drugs.
Where is Replidyne headquartered?
Replidyne is headquartered in St. Paul, US.
Which VCs invest in companies like Replidyne?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Replidyne's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Replidyne? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.